Roza L, De Gruijl F R, Bergen Henegouwen J B, Guikers K, Van Weelden H, Van Der Schans G P, Baan R A
TNO Medical Biological Laboratory, Rijswijk, The Netherlands.
J Invest Dermatol. 1991 Jun;96(6):903-7. doi: 10.1111/1523-1747.ep12475429.
To investigate the effect of visible light on the level of UV-induced thymine dimers in human epidermal cells in vivo, we exposed volunteers to UV-B alone, or to a serial combination of UV-B and visible light. Dimers were assayed in skin sections by immunofluorescence microscopy with a monoclonal antibody against the cyclobutyl thymine dimer. The dimer-specific fluorescence from epidermal cell nuclei, identified by counterstaining with propidium iodide, was quantified through computer-mediated image processing and analysis. After a single UV exposure (2-3 MED), significant dimer-specific fluorescence was measured, but no difference could be detected between skin kept in the dark after UV-irradiation and that exposed to visible light. In three other experiments, the UV dose was split into 3 parts (1 MED each), given at 2.5-h intervals. Half of the skin area was exposed to visible light following each dose fraction. After the second and third dose fractions, skin areas treated with visible light clearly showed lower levels of dimers (i.e., about 40% reduced) than skin kept in the dark. The results provide evidence that photorepair of dimers does occur in human skin, but not immediately after a first UV exposure of naive skin.
为了研究可见光对体内人表皮细胞中紫外线诱导的胸腺嘧啶二聚体水平的影响,我们将志愿者暴露于单独的UV-B或UV-B与可见光的连续组合下。通过使用抗环丁基胸腺嘧啶二聚体的单克隆抗体的免疫荧光显微镜在皮肤切片中检测二聚体。通过碘化丙啶复染鉴定的表皮细胞核的二聚体特异性荧光,通过计算机介导的图像处理和分析进行定量。单次紫外线照射(2-3个最小红斑量)后,测量到显著的二聚体特异性荧光,但紫外线照射后置于黑暗中的皮肤与暴露于可见光的皮肤之间未检测到差异。在其他三个实验中,紫外线剂量分为3部分(每次1个最小红斑量),每隔2.5小时给予一次。每次剂量部分后,一半的皮肤区域暴露于可见光下。在第二和第三剂量部分后,接受可见光处理的皮肤区域明显显示出比置于黑暗中的皮肤更低的二聚体水平(即降低约40%)。结果提供了证据表明二聚体在人皮肤中确实发生光修复,但不是在初次紫外线暴露于未接触过紫外线的皮肤后立即发生。